SCHEMBL23920549

SCHEMBL23920549

N[C@@H]1CNc2cc(Cl)ccc2O1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.39
ADAMTS5 Q9UNA0 2/20 0.38
HTR2C P28335 2/20 0.35
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CA2 P00918 2/20 0.34
CA1 P00915 1/20 0.34
ATF4 P18848 3/20 0.33
NR3C1 P04150 1/20 0.33
NR3C2 P08235 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
HTR3E A5X5Y0 1/20 0.33
HTR3B O95264 1/20 0.33
HTR3A P46098 1/20 0.33
HTR3D Q70Z44 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621076 1.00 AHR (0.39) AHRADAMTS5HTR2CKDM4EMEN1
SCHEMBL21882007 0.79 AKR1B1 (0.39) AHRADAMTS5HTR2CMAPTKMT2A
SCHEMBL21882006 0.79 AKR1B1 (0.39) AHRADAMTS5HTR2CMAPTKMT2A
SCHEMBL21882009 0.79 ADAMTS5 (0.38) AHRADAMTS5HTR2CKMT2AATF4
SCHEMBL21882013 0.79 AKR1B1 (0.39) AHRADAMTS5HTR2CMAPTKMT2A
SCHEMBL24997327 0.79 CA2 (0.40) ADAMTS5HTR2CCA2CA1ATF4
SCHEMBL30052791 0.79 CA2 (0.40) ADAMTS5HTR2CCA2CA1ATF4
SCHEMBL24997390 0.78 ADAMTS5 (0.49) ADAMTS5KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL30054581 0.78 ADAMTS5 (0.49) ADAMTS5KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL24997269 0.76 GBA1 (0.39) ADAMTS5HTR2CCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ALTOS LABS, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210317102-A1 INHIBITORS OF INTEGRATED STRESS RESPONSE PATHWAY ATF4, DDIT3, ATF1 AHR 3302/4885ADAMTS5 4307/4885HTR2C 1125/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.